My research focuses on improving in vitro diagnostics, facilitating therapeutics, and enabling life science research by developing stimuli-responsive polymeric reagents to streamline bioprocessing. Advances in healthcare rely on biotechnological improvements in clinical diagnostics, therapeutics as well as life science research. These areas of improvement are complimentary and provide great potential for translating academic research into commercial opportunities. Better clinical assays are required to detect biomarkers for diagnosis, prognosis, and therapeutic management of disease. Better therapeutics require efficient manufacturing processes for low-cost production of pure, stable, and effective therapeutics that meet regulatory and clinical requirements. Bioassays interface with therapeutic development by enabling a more thorough understanding of disease biology and of how a disease state can be modulated with a therapeutic candidate. Bioprocessing serves as an integral foundation. Therefore, my research has been focused on the development of stimuli-responsive polymeric reagents (e.g., nanoparticles, protein conjugates) for efficient biomarker isolation to enable infectious disease diagnosis, cancer biology study, etc.